Her-2 Positive Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-05-09
Clinical Trial Update: AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of AUY922 in combination with lapatinib and letrozole for ER-positive, HER2-positive advanced breast cancer has been withd…